ArticleNature communications2026
Four-dimensional reconfigurable vascular tunneling machine of spatially programmed liquid crystal elastomers.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombosis in tortuous vessels causes blockages and pathological conditions. Current thrombolytics are inefficient, and mechanical thrombectomies lack adaptability, hindering thrombus clearance in complex geometries. Here, we propose a 4D reconfigurable vascular tunneling machine (VTM) capable of synchronous rotation and elongation, mimicking teredo locomotion. The VTM operates via the reversible nematic-to-isotropic phase transition of liquid crystal elastomers, triggered by the reorientation of liquid crystal mesogens during a coupled contraction-torsion motion. Functionalized with magnetic liquid metals, the VTM achieves remote reconfiguration within 20 s via induction heating, with a temperature rise of only 1.1 °C and uniform heat dissipation. This rapid and safe thermal response facilitates the adaptive locomotion of the VTM within a cerebral artery model. Comprehensive biocompatibility evaluation confirms that the VTM exhibits no cytotoxicity and good hemocompatibility, and the VTM achieves the disruption of thrombus simulants across a stiffness range of 1 kPa to 1 MPa and sample retrieval up to 7.13 mm³. These demonstrations establish the VTM as a promising proof-of-concept platform, highlighting the potential for future development toward thrombus interventions and for operation as an adaptive soft robot in constrained environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.